Since 2007, we provide expert, personalized, evidence-based care through an integrated team approach. Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication a
nd compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy. We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology. OncoCare is one of Singapore's leading private oncology practices, offering comprehensive care across our 9 centres strategically located at Singapore's top-tier hospitals, including Gleneagles Medical Centre, Gleneagles Annexe Centre, Mount Elizabeth Orchard Medical Centre, Mount Elizabeth Novena Specialist Centre, Mount Alvernia Medical Centre, and Royal Square Medical Centre. In 2025, OncoCare partnered with Thomson Medical Group to establish Thomson-OncoCare Cancer Centre, extending our cancer care expertise to the Thomson ecosystem and reinforcing our commitment to accessible, high-quality oncology services across the region. Our core values are Excellence, Compassion and Integrity. AWARDS & ACCOLADES:
* OncoCare Cancer Centre is the first independent private cancer centre in Singapore to be awarded with the Singapore Quality Class with Service (September 2019). The Singapore Quality Class certification recognises organisations that have attained a commendable level of performance in their journey to achieve world-class standards of excellence.
* OncoCare Cancer Centre was also ranked 6th in the 2018 Enterprise 50 Awards. This recognition has spurred us toward continually improving and expanding our capabilities to provide better quality and more personalised cancer care. Established since 1995, the Enterprise 50 Awards recognises the TOP 50 local, privately owned companies that have contributed to the economic development in Singapore and overseas.
* OncoCare Cancer Centre has been awarded the prestigious Global Health Asia-Pacific award for Oncology Medical Centre of the Year in Asia Pacific-2022.
* In celebration of 30 years of establishment, the Children’s Cancer Foundation (CCF) of Singapore presented OncoCare Cancer Centre with a Philanthropy Award – Gold in Sep 2022 in recognition of our contributions through the years.
* Winner of the Singapore SME 1000 – Top Companies by Net Profit and Top Companies by Turnover, OncoCare Cancer Centre strives to be the best in its class as an independent private cancer centre in Singapore. The Singapore SME 1000 is a prestigious guide that has ranked the nation’s top-performing 1,000 companies by their financial performance for the past three decades.
